naion semaglutide use in patients with diabetes was associated with an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION) at 2, 3, and 4 years. https://ja.ma/4iZkMeV Semaglutide may be associated with
Description
Post-prandial GLP-1 secretion may therefore exert its anorectic effect through activating GLP-1Rs in gastric mucosa, which in turn increase mechanoreceptor firing and signalling to the NTS
Have been a patient of Dr
Winzeler B et al (2020) Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteers
The appetite reduction that makes semaglutide effective for weight loss can also lead to dangerously low fluid intake if users are not deliberately maintaining hydration
Additionally, bariatric surgery can lead to the remission of obesity-related comorbidities like type 2 diabetes and hypertension [13]
J Exp Clin Cancer Res
